Successful treatment of severe cytokine release syndrome after CAR-T therapy by ruxolitinib without compromising CAR-T efficacy

被引：4
|
作者：
Gu, Chengyuan [1 ,2 ,3 ]
Wu, Qian [1 ,2 ,3 ]
Zhang, Jingren [1 ,2 ,3 ]
Kang, Liqing [4 ,5 ]
Yu, Lei [4 ,5 ]
Qiu, Huiying [1 ,2 ,3 ]
Wu, Depei [1 ,2 ,3 ]
Chen, Suning [1 ,2 ,3 ]
Yang, Xiaofei [1 ,2 ,3 ,6 ]
机构：
[1] Soochow Univ, Natl Clin Res Ctr Hematol Dis, Jiangsu Inst Hematol, Affiliated Hosp 1, Suzhou, Peoples R China
[2] Inst Blood & Marrow Transplantat, Suzhou, Peoples R China
[3] Soochow Univ, Collaborat Innovat Ctr Hematol, Suzhou, Peoples R China
[4] East China Normal Univ, Sch Chem & Mol Engn, Shanghai, Peoples R China
[5] Shanghai Unicar Therapy Biomed Technol Co Ltd, Shanghai, Peoples R China
[6] oochow Univ, Jiangsu Inst Hematol, Natl Clin Res Ctr Hematol Dis, Affiliated Hosp 1, Suzhou 215000, Peoples R China
来源：
LEUKEMIA & LYMPHOMA | 2023年 / 64卷 / 02期
基金：
中国国家自然科学基金; 国家重点研发计划;
关键词：
D O I：
10.1080/10428194.2022.2148209
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：495 / 498
页数：4
相关论文
共 50 条
  • [1] SUCCESSFUL USE OF VA ECMO IN A CHILD WITH REFRACTORY CYTOKINE RELEASE SYNDROME AFTER CAR-T THERAPY
    Whalen, Allison
    Zivick, Elizabeth
    Cardona, Monika
    Lesher, Aaron
    Hudspeth, Michelle
    [J]. CRITICAL CARE MEDICINE, 2022, 50 (01) : 750 - 750
  • [2] Management of cytokine release syndrome related to CAR-T cell therapy
    Hongli Chen
    Fangxia Wang
    Pengyu Zhang
    Yilin Zhang
    Yinxia Chen
    Xiaohu Fan
    Xingmei Cao
    Jie Liu
    Yun Yang
    Baiyan Wang
    Bo Lei
    Liufang Gu
    Ju Bai
    Lili Wei
    Ruili Zhang
    Qiuchuan Zhuang
    Wanggang Zhang
    Wanhong Zhao
    Aili He
    [J]. Frontiers of Medicine, 2019, 13 : 610 - 617
  • [3] Management of cytokine release syndrome related to CAR-T cell therapy
    Chen, Hongli
    Wang, Fangxia
    Zhang, Pengyu
    Zhang, Yilin
    Chen, Yinxia
    Fan, Xiaohu
    Cao, Xingmei
    Liu, Jie
    Yang, Yun
    Wang, Baiyan
    Lei, Bo
    Gu, Liufang
    Bai, Ju
    Wei, Lili
    Zhang, Ruili
    Zhuang, Qiuchuan
    Zhang, Wanggang
    Zhao, Wanhong
    He, Aili
    [J]. FRONTIERS OF MEDICINE, 2019, 13 (05) : 610 - 617
  • [4] Extracorporeal cytokine removal in severe CAR-T cell associated cytokine release syndrome
    Stahl, Klaus
    Schmidt, Bernhard M. W.
    Hoeper, Marius M.
    Skripuletz, Thomas
    Mohn, Nora
    Beutel, Gernot
    Eder, Matthias
    Welte, Tobias
    Ganser, Arnold
    Falk, Christine S.
    Koenecke, Christian
    David, Sascha
    [J]. JOURNAL OF CRITICAL CARE, 2020, 57 : 124 - 129
  • [5] Emerging approaches for preventing cytokine release syndrome in CAR-T cell therapy
    Balagopal, Srinivas
    Sasaki, Koichi
    Kaur, Pooja
    Nikolaidi, Maria
    Ishihara, Jun
    [J]. JOURNAL OF MATERIALS CHEMISTRY B, 2022, 10 (37) : 7491 - 7511
  • [6] Biomarkers of cytokine release syndrome and neurotoxicity related to CAR-T cell therapy
    Wang, Zhenguang
    Han, Weidong
    [J]. BIOMARKER RESEARCH, 2018, 6
  • [7] CYTOKINE RELEASE SYNDROME (CRS) AND NEUROTOXICITY IN CAR-T CELL THERAPY PATIENTS
    Delrosario, Maria Regina
    Davison, Lisa
    Schwen, Sarah
    [J]. ONCOLOGY NURSING FORUM, 2019, 46 (02)
  • [8] Biomarkers of cytokine release syndrome and neurotoxicity related to CAR-T cell therapy
    Zhenguang Wang
    Weidong Han
    [J]. Biomarker Research, 6
  • [9] Interleukin Inhibitors in Cytokine Release Syndrome and Neurotoxicity Secondary to CAR-T Therapy
    Ferreros, Puri
    Trapero, Isabel
    [J]. DISEASES, 2022, 10 (03)
  • [10] Ruxolitinib reduces severe CRS response by suspending CAR-T cell function instead of damaging CAR-T cells
    Xu, Nan
    Yang, Xiao-Fei
    Xue, Sheng-Li
    Tan, Jing-Wen
    Li, Ming-Hao
    Ye, Jing
    Lou, Xiao-Yan
    Yu, Zhou
    Kang, Li-Qing
    Yan, Zhi-Qiang
    Yu, Lei
    Chen, Su-Ning
    Wang, Yi-Ting
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2022, 595 : 54 - 61
12345